Exelixis Stock Price (NASDAQ:EXEL)

Add to My Stocks
$22.4 $0.16 (0.72%) EXEL stock closing price Apr 28, 2017 (Closing)
28 APR 2017
amigobulls logo
EXEL hand_up
EXEL vs S&P 500
Closing Price: Apr 28, 2017
$22.4 ( 0.72%)
S&P 500
2384.2 ( -0.19%)
52 Week Price Range
1 Year Return: 389.87%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Exelixis Snapshot Video

17 5 2

EXEL Stock Details

Prev Close* : $22.24
Market Cap:
Day Low: $22.1
52 Week Low: $4.25
Open: $22.3
Volume: 2468510
Day High: $22.51
52 Week High: $23.49

Latest Stock Market News

Latest Articles

Exelixis News - From Partners

EXEL Stockcharts

View EXEL PE ratio, PS ratio stocks charts and compare with peers.
EXEL Chart
Note: Compare Exelixis stock price history with the index and industry peers.

Exelixis Valuation

PS ratio (
price to sales ratio

Exelixis Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

EXEL Industry Peers

Company Price Change (%)
Intermune (ITMN)73.890 (0%)
Qiagen (QGEN)30.090.11 (0.37%)
Bristol-myers Squibb (BMY)56.050.38 (0.68%)
Merck (MRK)62.330.25 (0.4%)
Roche Holdings (RHHBY)32.70.04 (0.12%)
Sanofi (SNY)47.30.39 (0.83%)
Swedish Orphan (SWTUY)15.280 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MiMedx (MDXG)12.691.29 (11.32%)
Regeneron Pharma (REGN)388.4921.87 (5.97%)
Evogene (EVGN)5.360.3 (5.93%)
Sarepta Therapeutics (SRPT)36.261.54 (4.44%)
Acorda Therapeutics (ACOR)16.150.6 (3.86%)
Alkermes (ALKS)58.251.95 (3.46%)
Heska (HSKA)108.253.03 (2.88%)
Top gainers from Medical-Biomed-Genetics industry
* As of Apr 28, 2017
CompanyPriceChange (%)
Sorrento Therapeutics (SRNE)1.950.15 (7.14%)
Revance (RVNC)21.751.55 (6.65%)
ZIOPHARM Oncology (ZIOP)7.040.47 (6.26%)
Alder BioPharma (ALDR)20.051.3 (6.09%)
Mirati Therapeutics (MRTX)4.550.23 (4.82%)
Idera Pharma (IDRA)2.350.1 (4.08%)
Curis (CRIS)2.420.1 (3.97%)
Top losers from Medical-Biomed-Genetics industry
* As of Apr 28, 2017

Exelixis, Inc. Stock News - Partner Headlines

Exelixis Financial Statements

income statement20162015201420132012
Net Sales Or Revenues191.45M37.17M25.11M31.33M47.45M
Net Income-70.22M-169.73M-268.54M-244.76M-147.64M
Total Operating Expense213.01M154.69M247.52M230.94M169.87M
view Exelixis, Inc. income statement
balance sheet20162015201420132012
Total Assets597.54M332.34M327.96M503.28M721.09M
Total Liabilities508.22M436.64M442.78M437.04M424.66M
Shareholders Equity89.31M-104.3M-114.82M66.23M296.43M
view Exelixis, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities227.26M-25.84M-10.27M-2.26M-8.63M
Net Cash From (Used By) Operating Activities206.29M-141.58M-235.4M-198.77M-123.14M
Increase (Decrease) In Prop Plant And Equipment-1.6M0.89M-0.08M-2.02M-0.77M
view Exelixis, Inc. cashflow statement

Exelixis Stock Message Board

Exelixis stock lost 1.09 %, and the last close price as of 27 Apr, 2017 is 22.24 for EXEL stock. Looking at Exelixis market capitalization, which currently stands at 6.43B, we can say that EXEL stock is a Mid cap stock. A value investor must look at the fundamentals of a stock, and perform Exelixis valuation, even though in the short-term sentiment and current breaking news might affect Exelixis stock price.

The terms stocks and shares mean the same thing. For Ex: Exelixis stock price and Exelixis share price mean the same thing. The volume of shares traded stood at 2247513 on the last trading day, as is evident from Exelixis stock chart, and EXEL stock quote data. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Exelixis does not pay dividends. Exelixis stock price history, gives the entire historical data for EXEL stock.